Integral Health Asset Management LLC Has $25.40 Million Stock Holdings in Encompass Health Corporation $EHC

Integral Health Asset Management LLC lowered its stake in Encompass Health Corporation (NYSE:EHC) by 37.5% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 200,000 shares of the company’s stock after selling 120,000 shares during the quarter. Encompass Health comprises approximately 1.7% of Integral Health Asset Management LLC’s holdings, making the stock its 13th largest holding. Integral Health Asset Management LLC owned 0.20% of Encompass Health worth $25,404,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Royal Bank of Canada grew its position in shares of Encompass Health by 21.5% during the 1st quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock worth $8,960,000 after buying an additional 15,677 shares during the period. Millennium Management LLC raised its position in shares of Encompass Health by 38.4% in the 1st quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock valued at $9,338,000 after acquiring an additional 25,574 shares during the period. Caxton Associates LLP bought a new position in Encompass Health during the 1st quarter worth approximately $259,000. Savant Capital LLC grew its holdings in Encompass Health by 7.4% during the second quarter. Savant Capital LLC now owns 3,121 shares of the company’s stock valued at $383,000 after purchasing an additional 214 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new stake in Encompass Health in the second quarter valued at approximately $306,000. 97.25% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, Treasurer Edmund Fay sold 11,937 shares of the stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the completion of the transaction, the treasurer directly owned 89,325 shares of the company’s stock, valued at approximately $9,557,775. This represents a 11.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Mark J. Tarr sold 150,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $111.64, for a total value of $16,746,000.00. Following the transaction, the chief executive officer directly owned 377,070 shares in the company, valued at $42,096,094.80. This trade represents a 28.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 2.00% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on EHC. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday, January 18th. Zacks Research cut shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. Finally, Barclays raised their price objective on Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a research note on Friday, February 6th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, Encompass Health presently has a consensus rating of “Buy” and a consensus target price of $143.29.

Encompass Health Stock Up 0.2%

Shares of EHC stock opened at $100.52 on Friday. Encompass Health Corporation has a 12-month low of $92.77 and a 12-month high of $127.99. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.76. The firm has a fifty day moving average of $103.58 and a 200-day moving average of $113.04. The company has a market capitalization of $9.99 billion, a price-to-earnings ratio of 18.14, a P/E/G ratio of 1.92 and a beta of 0.71.

Encompass Health (NYSE:EHC) last released its earnings results on Thursday, February 5th. The company reported $1.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.29 by $0.17. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.The firm had revenue of $3.09 billion during the quarter, compared to analysts’ expectations of $1.54 billion. During the same quarter in the prior year, the company earned $1.17 EPS. The company’s revenue was up 9.9% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. As a group, equities research analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st will be issued a $0.19 dividend. The ex-dividend date is Wednesday, April 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.8%. Encompass Health’s dividend payout ratio (DPR) is 13.72%.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.